Verrica Pharmaceuticals (STU:1NE) Price-to-Operating-Cash-Flow : (As of Jun. 19, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Verrica Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-06-19), Verrica Pharmaceuticals's share price is €7.495. Verrica Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.08. Hence, Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:1NE's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.955
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Verrica Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.40. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.08.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year.

During the past 8 years, Verrica Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.80% per year. The lowest was -138.70% per year. And the median was 5.80% per year.

Verrica Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verrica Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Verrica Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Verrica Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Verrica Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	7.495	/	-1.077
	=

Verrica Pharmaceuticals's Share Price of today is €7.495.
Verrica Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.08.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Verrica Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Verrica Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Verrica Pharmaceuticals (STU:1NE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (STU:1NE) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

VRCA:USA

Address

44 West Gay Street, Suite 400, West Chester, PA, USA, 19380

Website

https://www.verrica.com

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals (STU:1NE) Headlines

No Headlines